Table 2.
Control subjects (n = 10) | PKU subjects (n = 12) | p | |
---|---|---|---|
∆ HR (beats/min) | 25 (17–32) | 21.5 (14–30.5) | 0.473 |
∆ Systolic BP (mmHg) | 16 (5.5–23) | 16.5 (14–24.7) | 0.472 |
∆ Diastolic BP (mmHg) | 12 (4.5–20) | 15.5 (8.5–17.7) | 0.638 |
∆ Phe (μmol/L) | 0.8 (− 2.7–2.0) | 7.3 (− 12.9–48.7) | 0.764 |
∆ Tyr (μmol/L) | 0.4 (− 5.5–3.1) | 3.2(− 1.6–11.6) | 0.211 |
∆ NE (pg/ml) | 61.6 (22.3–190.5) | 81.9 (31.8–103.4) | 0.915 |
∆ E (pg/ml) | 10.9 (7.4–45.4) | 17.9 (8.7–53.8) | 0.680 |
Values are presented as median (25th and 75th percentiles)
Abbreviations: ∆ change from resting, HR heart rate, BP blood pressure, Phe phenylalanine, Tyr tyrosine, NE norepinephrine, E epinephrine